Democrats Won Congress. Grant Seekers Should Plan for December 11 Before January 3

For the research and nonprofit world, the most important date after Tuesday's election is not January 3, 2027, when a Democratic House majority is sworn in. It is December 11, 2026, when the stopgap funding law runs out. The outgoing Congress, with its Republican majorities and some members who now know they are leaving, will decide what happens that day.

That gap between who won and who still holds the gavel matters more than any victory-night quote. Grant applicants who read the results as "the cuts are over" will plan badly. Applicants who read the calendar correctly can use the next five weeks.

What the results actually changed

NBC News projects that Democrats will hold about 255 House seats, up from a narrow minority. That would likely be the party's biggest majority in nearly two decades. NBC also projects that Democrats flipped the Senate, giving them both chambers for the first time in President Trump's second term. Hakeem Jeffries is expected to be sworn in as Speaker on January 3.

Several changes affect grant seekers directly:

• Committee gavels change hands. Democrats will chair the appropriations committees that fund agencies and the oversight committees that investigate them. Chemistry World reports that Rep. Zoe Lofgren, ranking member of the House Science, Space and Technology Committee, is in line to chair it. That committee covers non-defense, non-health federal research, including NSF, NIST, DOE's Office of Science and NASA. Lofgren says she will work to "put a stop to Trump's politicisation of science."
• Subpoena power arrives. Majority control gives House committees subpoena authority. Agency heads who have run slow obligation rates or diverted funds can now be compelled to explain themselves under oath.
• The Senate appropriations dynamic shifts, and not only in Democrats' favor. Nature reports that Senate Appropriations Chair Susan Collins (R-Maine) lost her re-election race. Collins was the Republican who pushed back hardest on the administration's grant rule and protected science lines in committee. Her departure removes a cross-party ally that research advocates had relied on, even as the gavel moves to Democrats.

The new members also include scientists: microbiologist Jasmine Clark, public health expert Abdul El-Sayed, and environmental engineer Christina Bohannan.

Why experts are telling you to keep expectations low

The research community's first reaction was relief. Neal Lane, the former NSF director now at Rice University's Baker Institute, told Chemistry World that "the enormous damage Trump and his enablers have done to science will be repaired and politics will not replace merit peer review in grant decisions."

Lane also added a caveat in the same breath: "The White House is still in Republican hands, so rebuilding American science will not happen overnight." Tobin Smith, senior vice president for government relations at the Association of American Universities, put it more bluntly: "no one should expect an immediate or dramatic shift in congressional support for science." He said the administration will keep shaping research through "executive actions, regulatory decisions and the presidential veto."

On October 30, in an interview with the New York Post, Trump said he would use his veto to block Democratic legislation. The new majorities are large, but neither chamber is near the two-thirds needed to override a veto without Republican votes. Colette Delawalla of Stand Up for Science told WGBH that Democrats should keep sending science bills and make the president veto "every last one of those." That approach puts the votes on the record. It does not get money out the door.

Nature's reporting points the same way: even with Democratic control, appropriators will find it hard to do more than hold science funding roughly steady, because every spending bill still needs the president's signature.

For grant seekers, this means 2027 is a year of oversight and leverage, not windfalls. Expect hearings, document requests and pressure on agencies to spend money Congress has already appropriated. Don't expect a supplemental appropriation that reverses two years of cuts.

The December 11 problem

The September stopgap keeps the government funded through December 11 at FY2026 levels. As we covered in our analysis of the Senate's freeze on OMB's grant rule, it also blocks OMB from finalizing or implementing its rewrite of the Uniform Guidance (2 CFR 200) until that date. That rewrite would add pre-issuance review of discretionary awards by political appointees and allow termination when an award no longer serves "the national interest."

The House Appropriations Committee has reported all 12 FY2027 bills, and the full House has passed three. As of September, the Senate committee had reported none. Congress returns on November 9 with a crowded lame-duck agenda: appropriations, the FY2027 NDAA, the Farm Bill and surface transportation reauthorization, which also expires December 11.

That leaves three realistic paths:

1. Another continuing resolution into early 2027. This is the most likely outcome, and it is now more attractive to Democrats, who gain leverage by pushing final FY2027 decisions into a Congress they control. Watch whether the new CR renews the OMB rule freeze. If it does, the rule stays blocked until the next deadline.
2. An omnibus or a set of minibus packages. Outgoing Republican leaders may want to lock in FY2027 toplines before losing the majority. A full-year deal would settle agency budgets but could leave the OMB rule unaddressed.
3. A lapse for some agencies. This is less likely after an election that punished the governing party, but this Congress has let funding lapse before.

The scenario that matters most is the second half of option one: the freeze on the OMB rule ends on December 11 unless Congress renews it. Comments on the rule closed in July. If the freeze lapses, OMB could finalize within weeks, before the new Congress is seated. A Democratic Congress could try to override it under the Congressional Review Act or through appropriations riders. The CRA requires the president's signature or a veto override, though, so a rule finalized in December could survive the change in majority.

NSF has already pulled four OMB-derived provisions from its revised Guidance on Financial Assistance, but only until the government-wide rule is final. We broke down that conditional retreat in NSF Pulled the OMB-Only Language Out of Its New Grant Rulebook. What happens on December 11 decides whether that retreat holds.

Where oversight pressure will land first

Grant seekers should watch where the new chairs are likely to aim first, because that is where agency behavior changes fastest.

NSF's carryover. NSF closed FY2026 having obligated $6.4 billion across 6,218 awards, down from $8.3 billion and 8,647 awards the year before. It carried about $1.7 billion into FY2027, roughly $1 billion of it reportedly set aside for the White House OSTP Grand Research Challenges initiative. In August, Lofgren co-signed a letter accusing OSTP of directing money Congress never appropriated to it. As chair, she can hold hearings and subpoena records on the same question. Our breakdown of where NSF's FY2026 money went shows why directorate-level choices matter for FY2027 submissions.

NIH terminations. NIH has delayed or canceled more than 2,000 biomedical research grants since early 2025. Many were restored after litigation. In January, a federal appeals court in Boston heard the government's appeal of a district ruling that NIH acted unlawfully when it terminated hundreds of grants. The same courthouse upheld an injunction blocking the cap on indirect cost rates. Scott Delaney of Grant Witness told WGBH that in Massachusetts alone, "more than 200 grants totaling more than $500 million were never restored," and he expects congressional pressure on HHS to resume.

Obligation pace generally. Christopher Fisher, founder of Multivalent Communications, told Chemistry World that agency directors "will likely be forced to defend delays in grant funding authorised by Congress." That kind of public questioning is one of the few tools that moves money without a new law. Agencies that know a hearing is coming tend to clear their backlogs first.

What to do between now and January

Push pending awards toward obligation before December 11. If your proposal is in a fundable range or your award is in final negotiation, ask your program officer when it can be obligated. Awards issued under the current rules are not subject to whatever OMB finalizes later. The case for closing early holds regardless of who controls Congress in January.

Don't hold submissions waiting for a better climate. Paylines and program budgets for the rest of FY2027 will be set by a CR or a deal negotiated mostly by the outgoing Congress. Submit on the deadlines you have. Proposals delayed until spring will compete under the same budget with less time.

Document termination and delay harms now. Incoming oversight staff will want specific cases: grant numbers, dates, dollar amounts, the people and projects affected. Organizations that can provide a clean record to their delegation's staff in January will shape the hearings. Organizations that wait won't.

Keep diversifying revenue. Two years of terminations showed what dependence on one federal source costs, and divided government with a veto-wielding White House does not change that. Foundation, state and earned-revenue lines still matter. See our analysis of federal funding volatility and grant diversification.

Read the December bill for riders, not just the topline. The most important text in the next funding law may be a single sentence extending the OMB rule freeze, or the absence of that sentence. Research offices and nonprofit compliance staff should have someone ready to read the bill text the day it posts.

The election changed who will be asking questions in 2027. It did not change who signs spending bills, and it did not move the December deadline. Grant seekers who focus on December 11 now will be better prepared for a 2027 that brings more oversight but not much new money. When you're ready to turn a pending idea into a submission before the window shifts, Granted can help you draft the proposal.